Triple oral combination therapy with macitentan, riociguat, and selexipag for pulmonary arterial hypertension:

Background:The evidence regarding triple oral combination therapy for patients with pulmonary arterial hypertension (PAH) is scarce. This study was performed to investigate the effectiveness and sa...